A Novel Flow Diverter (Tubridge) for the Treatment of Recurrent Aneurysms: A Single-Center Experience.
10.3348/kjr.2017.18.5.852
- Author:
Yongxin ZHANG
1
;
Qing Hai HUANG
;
Yibin FANG
;
Pengfei YANG
;
Yi XU
;
Bo HONG
;
Jianmin LIU
Author Information
1. Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China. chstroke@163.com
- Publication Type:Brief Communication
- Keywords:
Intracranial aneurysms;
Flow diverter;
Recurrent aneurysms
- MeSH:
Aneurysm*;
Aneurysm, Dissecting;
Angiography;
Arteries;
Constriction, Pathologic;
Follow-Up Studies;
Humans;
Intracranial Aneurysm;
Neck;
Parents;
Prospective Studies;
Recurrence;
Retreatment;
Vertebral Artery
- From:Korean Journal of Radiology
2017;18(5):852-859
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The Tubridge flow diverter (FD) is a novel device aimed at reconstructing the parent artery and occluding complex aneurysms. Retreatment of recurrent aneurysms using the FD is challenging. We report our initial experience in the repair of aneurysm recurrence with the FD. MATERIALS AND METHODS: A database was reviewed prospectively, and 8 patients with 8 recurrent aneurysms (mean size, 16.7 mm) were identified. Four aneurysms had previously ruptured. The previous aneurysm treatment consisted of coiling in 1 aneurysm and single-stent-assisted coiling in 7 aneurysms. The procedural complications and clinical and angiographic outcomes were analyzed. RESULTS: Six aneurysms were treated by using a single Tubridge FD alone, while the remaining 2 were treated with FD + coiling. The immediate results of the 8 aneurysms were that they all showed incomplete occlusion. Neither major ischemic nor hemorrhagic complications occurred; however, 1 patient experienced a vasospasm. Follow-up angiographies were available for 7 aneurysms; the mean follow-up was 16.9 months (7–36 months). Five aneurysms were completely occluded, whereas 2 had a residual neck. Severe asymptomatic stenosis of 1 parent artery of a vertebral artery dissecting aneurysm was found. All visible branches covered by the FD were patent. All patients were clinically assessed as having attained a favorable outcome (modified Rankin Scale score ≤ 2) at discharge and follow-up. CONCLUSION: In selected patients, the Tubridge FD can provide a safe and efficient option for the retreatment of recurrent aneurysms. Nevertheless, attention should be paid to several technical points.
